Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic New Options for Treating Neurological Disease: Stem Cell Therapy Decision Resources, Inc., Dec 2006, Pages: 25   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   Stem cell therapy development is challenged by controversy, intellectual property issues, and a high failure rate. Despite these challenges, stem cell therapy presents some of the most promising options for hard-to-treat and highly degenerative neurological diseases. Get the Answers You Need to Shape Your Strategy Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that are incapable of autonomous healing, such as the central nervous system (CNS). How can stem cells boost healing in the CNS? What are the limitations of these therapies in the CNS? What scientific and regulatory roadblocks exist for developing stem cell therapies for the CNS? Several manufacturers are investigating stem cell therapies to treat neurological disease. What are the different approaches for developing these therapies? What value do different stem cell therapies offer, and what challenges do they face? How might these agents impact the different disease markets? Stem cell therapies may represent the first true disease-modifying therapies for multiple neurological diseases, but their success will depend on many factors, including ethics, clinical trial design, and safety concerns. How are ethics affecting stem cell design? What can we expect from future stem cell clinical trials? Which stem cell therapies are likely to offer the best safety profiles? Scope Stem cell introduction: stages of stem cell differentiation, comparison of stem cell types, history of stem cell development. Value of stem cells for neurological diseases: benefi ts and limitations of stem cells and their therapeutic value for multiple neurological indications, including Alzheimer’s disease and Parkinson’s disease. Emerging stem cell therapies for neurological uses: discussion of multiple companies’ initiatives into developing neurological stem cell therapies. Outlook: hurdles for stem cell therapy development, discussion of which stem cell therapies are more likely to succeed. Customers who bought this item also bought Gene Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies Stem Cells--Emerging Markets and Growth Opportunities (Technical Insights) Applications of Stem Cells in Drug Discovery Market Analysis The Emergence of Stem Cell Research and Therapy Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies Cell Therapy Commercialization - Applying Stem Cell and Related Strategies Gene Therapy: Current Status and Prospects

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster